Cedric Chevalier

Dijon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer.

Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer.

Journal: Oncoimmunology

Published: February 27, 2026

Chemoimmunotherapy for localized non-small cell lung cancer: A new standard for all stage III?

Chemoimmunotherapy for localized non-small cell lung cancer: A new standard for all stage III?

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: August 28, 2025

ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors.

ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 24, 2025

Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma.

Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma.

Journal: PloS one

Published: January 15, 2024

A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ study.

A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ study.

Journal: Radiation oncology (London, England)

Published: January 06, 2024

Deep learning application for abdominal organs segmentation on 0.35 T MR-Linac images.

Deep learning application for abdominal organs segmentation on 0.35 T MR-Linac images.

Journal: Frontiers in oncology

Published: August 30, 2023

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.

Journal: BMC cancer

Published: February 24, 2023

Extreme hypofractionated radiation therapy for pancreatic cancer

Extreme hypofractionated radiation therapy for pancreatic cancer

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: June 22, 2021

Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.

Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.

Journal: BMC immunology

Published: January 15, 2021

Evaluation of the quality of the information received during head and neck cancer announcement: Prospective two-center study.

Evaluation of the quality of the information received during head and neck cancer announcement: Prospective two-center study.

Journal: Head & neck

Published: July 01, 2019

Salvage brachytherapy as a modern reirradiation technique for local cancer failure: The Phoenix is reborn from its ashes.

Salvage brachytherapy as a modern reirradiation technique for local cancer failure: The Phoenix is reborn from its ashes.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: December 05, 2017

Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.

Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.

Journal: Journal of neuro-oncology

Published: August 01, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026